The customer stated that they received erroneous results for one patient sample tested for elecsys brahms pct (pct) on a cobas e 411 immunoassay analyzer (e411).It was asked, but it is not known if an erroneous result was reported outside of the laboratory.The sample initially resulted as > 100 ng/ml.The sample was diluted x10 and repeated three times, resulting as 5.8 ng/ml, 5.8 ng/ml, and 5.5 ng/ml.The sample was repeated on (b)(6) 2017, resulting as 80.64 ng/ml.The sample was also diluted x10 and repeated on (b)(6) 2017, resulting as 5.8 ng/ml.No adverse events were alleged to have occurred with the patient.The e411 analyzer serial number was (b)(4).
|
An update of the repeat results that were obtained at the customer site was provided.The sample was provided for investigation, where it was tested on a cobas e 411 immunoassay analyzer.The sample was measured without dilution and after dilution with both multiassay diluent and pct negative patient serum.The e411 analyzer used for investigation was serial number (b)(4).Pct reagent lot number 203580, with an expiration date of april 2018 was used on this analyzer.The customer results could not be reproduced.The results of the diluted sample obtained during investigations was much higher than those obtained by the customer.The reason why the customer obtained much lower results in dilutions must be related to an unknown local issue within the customer lab.Per product labeling, only samples with results that are outside of the measuring range (>100 ng/ml) should be diluted.The low recovery with diluted sample measurements in the investigation can be attributed to dilutions performed outside of product labeling recommendations.
|